SCHEMBL23748712

SCHEMBL23748712

CCC=CCOc1cccc(C(=O)O)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.40
TLR2 O60603 1/20 0.40
TLR1 Q15399 1/20 0.40
TLR6 Q9Y2C9 1/20 0.40
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
PTK2B Q14289 1/20 0.40
KDM4E B2RXH2 3/20 0.39
TSHR P16473 2/20 0.39
RAB9A P51151 2/20 0.39
HTT P42858 1/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 1/20 0.39
MITF O75030 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
ESR1 P03372 1/20 0.38
ITGB3 P05106 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748646 1.00 PTGER1 (0.46) PTGER1MRGPRX4TLR2TLR1TLR6
SCHEMBL23748683 0.88 KMT2A (0.44) ALDH1A1KMT2AKDM4ERAB9AHTT
SCHEMBL28609496 0.88 KMT2A (0.44) ALDH1A1KMT2AKDM4ERAB9AHTT
SCHEMBL31729565 0.87 RAB9A (0.40) PTGER1KMT2ARAB9AMAPK1MEN1
SCHEMBL31729568 0.87 RAB9A (0.40) PTGER1KMT2ARAB9AMAPK1MEN1
SCHEMBL31729567 0.87 RAB9A (0.40) PTGER1KMT2ARAB9AMAPK1MEN1
Potassium Ion SCHEMBL31729564 0.87 RAB9A (0.40) PTGER1KMT2ARAB9AMAPK1MEN1
SCHEMBL24087407 0.86 TSHR (0.50) ALDH1A1KMT2APTK2BKDM4ETSHR
SCHEMBL23748684 0.86 ALDH1A1 (0.44) PTGER1MRGPRX4TLR2TLR1TLR6
SCHEMBL28620825 0.86 ALDH1A1 (0.44) PTGER1MRGPRX4TLR2TLR1TLR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US claimed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US claimed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP claimed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN claimed
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 PTGER1 628/4885MRGPRX4 419/4885TLR2 2218/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 PTGER1 628/4885MRGPRX4 419/4885TLR2 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.